Agendia BV, a world leader in the rapidly evolving field of cancer
molecular diagnostics has appointed six members to its Clinical and
Scientific Advisory Board. The newly established Clinical and Scientific
Advisory Board is comprised of internationally-recognized scientists with
research and clinical expertise. The advisors review early research programs
and provide critical evaluations from academic and clinical perspectives.
